Clinical Trials Logo

Filter by:
NCT ID: NCT05485610 Recruiting - Clinical trials for Diminished Ovarian Reserve

Effect of NMN (Nicotinamide Mononucleotide) on Diminished Ovarian Reserve (Including Premature Ovarian Insufficiency)

Start date: July 1, 2022
Phase: N/A
Study type: Interventional

The purpose of the study is to understand the effect of nicotinamide mononucleotide (NMN) on patients with diminished ovarian reserve (including premature ovarian insufficiency).

NCT ID: NCT05485103 Recruiting - Clinical trials for Inflammatory Bowel Diseases

A Prospective Study of the Effect of Modified Colonoscopy Bowel Preparation Program on Intestinal Cleaning, Examination and Disease in Patients With Inflammatory Bowel Disease

Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate the effect of modified colonoscopy bowel preparation method compared with traditional method on bowel cleansing effect, colonoscopy examination effect and clinical condition of inflammatory bowel disease patients. Risk factors affecting the quality of bowel preparation will also be studied.

NCT ID: NCT05485077 Recruiting - Colorectal Cancer Clinical Trials

A Prospective Cohort Study on Colorectal Cancer Screening in Community Population

Start date: July 9, 2022
Phase:
Study type: Observational

This study will validate the real world results of polygene methylation detection in colorectal cancer in a large prospective community cohort. In this study, questionnaire survey and polygene methylation detection technology of colorectal cancer were used as preliminary screening methods, and colonoscopy was used as further validation examination method to screen colorectal cancer and precancerous lesions. The diagnosis and outcome of all lesions were based on colonoscopy and pathological examination.

NCT ID: NCT05484921 Recruiting - Clinical trials for TBI (Traumatic Brain Injury)

Clinical Significance of circMETTL9 Gene in Traumatic Brain Injury

Start date: August 4, 2022
Phase:
Study type: Observational

Objective: The relevance of circMETTL9 to the degree of injury, disturbance of consciousness, cognitive function and prognosis in patients with moderate to severe traumatic brain injury (TBI) remains unknown. The purpose of this study was to investigate the effect of circMETTL9 on the degree of injury, disturbance of consciousness, cognitive function and prognosis after TBI.

NCT ID: NCT05484908 Recruiting - Clinical trials for Hepatocellular Carcinoma

Efficacy and Safety of ALSS Treatment for ICIs-LF in Patients With HCC

Start date: August 12, 2022
Phase: N/A
Study type: Interventional

This study aims to investigate the efficacy and safety of artificial liver support system treatment for immune checkpoint inhibitors related liver failure in patients with hepatocellular carcinoma.

NCT ID: NCT05484817 Recruiting - Diabetes Mellitus Clinical Trials

Early Assessment of Impaired Cardiac Function in Patients With Diabetes Mellitus

Start date: June 1, 2022
Phase:
Study type: Observational

This is a single-center, prospective, observational study to explore the clinical features and risk factors of impaired cardiac function detected by two-dimensional speckle tracking echocardiography in patients with diabetes mellitus. The risk factors include traditional cardiovascular risk factors, bone metabolism hormones, sex hormones, adrenal and pituitary hormones, and novel serum biomarkers.

NCT ID: NCT05484466 Recruiting - Clinical trials for Hepatitis B, Chronic

A Study to Evaluate the Efficacy and Safety of ZM-H1505R in Combination With ETV Compared With ETV Monotherapy in Patients With CHB

Start date: November 11, 2022
Phase: Phase 2
Study type: Interventional

This is a multicenter, randomized, double-blind, placebo-controlled phase IIa study, designed to evaluate the efficacy and safety of ZM-H1505R in combination with Baraclude versus Baraclude monotherapy in adult CHB subjects with HBV DNA <2000 IU/mL but ≥ 50 IU/mL and who have received ETV (0.5 mg, once daily [QD)] monotherapy for at least 12 months. The study is planned to enroll 90 adult CHB subjects who have received ETV monotherapy for at least 12 months and are still receiving ETV monotherapy (0.5 mg, QD) continuously. Eligible subjects will be randomized in a 1:1:1 ratio into 3 treatment groups. Both HBeAg positive and negative subjects will be included. There will be 20 HBeAg positive subjects and 10 HBeAg negative subjects in each treatment group. After 48 weeks of treatment with the corresponding regimen, subjects will continue to take Baraclude 0.5 mg QD, as a monotherapy for a 12-week follow-up period for observation of efficacy and safety of ZM-H1505R.

NCT ID: NCT05483881 Recruiting - Respiratory Disease Clinical Trials

the Effects of Air Pollution on Respiratory Diseases in Children

Start date: May 15, 2022
Phase:
Study type: Observational

The investigators expect to reveal the association between air pollution and childhood respiratory diseases through a multi-center observational study, and summarize the relationship between air pollution and childhood respiratory diseases.

NCT ID: NCT05483543 Recruiting - Clinical trials for Limited Stage Small Cell Lung Cancer

Pamiparib for Consolidation Treatment of Unprogressed LS-SCLC After Concurrent Chemoradiotherapy

Start date: June 20, 2022
Phase: Phase 2
Study type: Interventional

This study is a prospective, single-arm, phase II clinical trial, with 1-year PFS as the endpoint, to evaluate the efficacy and associated toxicity of Pamiparib as single-agent consolidation treatment in patients with limited-stage small cell lung cancer(LS-SCLC) patients who have not progressed following platinum-based concurrent chemoradiotherapy(cCRT) .

NCT ID: NCT05483452 Recruiting - Clinical trials for Accuracy of Coplanar Template Assisted Seed Implantation for Abdominal and Pelvic Cancer

Accuracy of Coplanar Template Assisted Seed Implantation for Abdominal and Pelvic Cancer

Start date: March 1, 2024
Phase:
Study type: Observational [Patient Registry]

In recent years, template guidance has been applied and developed in the field of puncture related operations, such as template-assisted radioactive seed implantation. With the guidance of template, needle pathway of seed implantation, biopsy and fiducial marker implantation can be precisely planned actual operation, which is conducive to the accurate proceeding. Templates can be divided into coplanar templates and non-coplanar templates. The digital coplanar template coordinate puncture system has been developed in China and has been applied in clinical practice. In previous studies, coplanar template assisted CT-guided radioactive seed implantation has good clinical feasibility for head and neck cancer. However, the accuracy of Coplanar Template Assisted Seed Implantation for Abdominal and Pelvic cancer are lacking in prospective studies. The study aims to prospectively observe the accuracy and safety of Coplanar Template Assisted Seed Implantation for Abdominal and Pelvic cancer.